Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Vascular & Endovascular: Stroke risk increases with age for TAVR patients | Mobile stroke units improve outcomes

News You Need to Know Today
Vascular & Endovascular: Stroke risk increases with age for TAVR patients | Mobile stroke units improve outcomes
Wednesday, April 21, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Vascular & Endovascular

How patient care changes when stroke centers offer endovascular thrombectomy

Researchers simulated more than 80 million patient encounters, running a variety of models to gain as much insight as possible. 

READ MORE >
Hospital staff walking through a medical facility, intentionally blurred to look artistic
Share on Twitter Share on Facebook Share on Linkedin

How patient care changes when stroke centers offer endovascular thrombectomy

Share on Twitter Share on Facebook Share on Linkedin
Hospital staff walking through a medical facility, intentionally blurred to look artistic
Researchers simulated more than 80 million patient encounters, running a variety of models to gain as much insight as possible. 
READ MORE >

Risk of death, stroke increases with age for TAVR patients

The risk of post-TAVR pacemaker implantation also goes up when treating elderly patients. 

READ MORE >
Elderly
Share on Twitter Share on Facebook Share on Linkedin

Risk of death, stroke increases with age for TAVR patients

Share on Twitter Share on Facebook Share on Linkedin
Elderly
The risk of post-TAVR pacemaker implantation also goes up when treating elderly patients. 
READ MORE >

USPSTF shares recommendation on screening asymptomatic adults for atrial fibrillation

The organization is accepting public comments on this topic until May 17.

READ MORE >
The American College of Cardiology and American Heart Association have collaborated on a new update to the much-discussed 2021 chest pain guidelines. The American College of Emergency Physicians and Society for Cardiac Angiography and Interventions also contributed to the document.
Share on Twitter Share on Facebook Share on Linkedin

USPSTF shares recommendation on screening asymptomatic adults for atrial fibrillation

Share on Twitter Share on Facebook Share on Linkedin
The American College of Cardiology and American Heart Association have collaborated on a new update to the much-discussed 2021 chest pain guidelines. The American College of Emergency Physicians and Society for Cardiac Angiography and Interventions also contributed to the document.
The organization is accepting public comments on this topic until May 17.
READ MORE >

US recommends pause of Johnson & Johnson COVID-19 vaccine due to blood clot risk

The FDA and CDC announced the recommendation in a new joint statement. Nearly 7 million doses of the Johnson & Johnson vaccine have been administered in the United States so far. 

READ MORE >
COVID-19 vaccines help reduce the serious coronavirus infections and hospitalizations. Multiple studies have shown that the risk from very rare vaccine side effects are far outweighed by the much greater risk of hospitalization and death due to COVID infections.
Share on Twitter Share on Facebook Share on Linkedin

US recommends pause of Johnson & Johnson COVID-19 vaccine due to blood clot risk

Share on Twitter Share on Facebook Share on Linkedin
COVID-19 vaccines help reduce the serious coronavirus infections and hospitalizations. Multiple studies have shown that the risk from very rare vaccine side effects are far outweighed by the much greater risk of hospitalization and death due to COVID infections.
The FDA and CDC announced the recommendation in a new joint statement. Nearly 7 million doses of the Johnson & Johnson vaccine have been administered in the United States so far. 
READ MORE >

AstraZeneca COVID-19 vaccine associated with risk of rare, potentially fatal blood clots

These blood clots have been responsible for a total of 18 deaths. Experts have continued to emphasize that the benefits of vaccination still outweigh the risks.

READ MORE >
Vaccination
Share on Twitter Share on Facebook Share on Linkedin

AstraZeneca COVID-19 vaccine associated with risk of rare, potentially fatal blood clots

Share on Twitter Share on Facebook Share on Linkedin
Vaccination
These blood clots have been responsible for a total of 18 deaths. Experts have continued to emphasize that the benefits of vaccination still outweigh the risks.
READ MORE >

Beta-blockers raise the risk of heart disease, stroke among people with HIV

The study, published in Hypertension, included data from more than 8,000 U.S. veterans.

READ MORE >
patient with heart doctor
Share on Twitter Share on Facebook Share on Linkedin

Beta-blockers raise the risk of heart disease, stroke among people with HIV

Share on Twitter Share on Facebook Share on Linkedin
patient with heart doctor
The study, published in Hypertension, included data from more than 8,000 U.S. veterans.
READ MORE >

Patients with pulmonary arterial hypertension benefit from sotatercept treatment

After 24 weeks, treatment with sotatercept was associated with a significant reduction in pulmonary vascular resistance.

READ MORE >
Doctor mask covid
Share on Twitter Share on Facebook Share on Linkedin

Patients with pulmonary arterial hypertension benefit from sotatercept treatment

Share on Twitter Share on Facebook Share on Linkedin
Doctor mask covid
After 24 weeks, treatment with sotatercept was associated with a significant reduction in pulmonary vascular resistance.
READ MORE >

CT perfusion a key tool for evaluating stroke patients—but utilization remains low

The analysis, published in Circulation: Cardiovascular Quality and Outcomes, included data from more than 87,000 Medicare patients. 

READ MORE >
stroke
Share on Twitter Share on Facebook Share on Linkedin

CT perfusion a key tool for evaluating stroke patients—but utilization remains low

Share on Twitter Share on Facebook Share on Linkedin
stroke
The analysis, published in Circulation: Cardiovascular Quality and Outcomes, included data from more than 87,000 Medicare patients. 
READ MORE >

Mobile stroke units improve patient outcomes, reduce risk of disability

Researchers tracked data from more than 1,000 patients who received care from 2014 to 2020. 

READ MORE >
stroke
Share on Twitter Share on Facebook Share on Linkedin

Mobile stroke units improve patient outcomes, reduce risk of disability

Share on Twitter Share on Facebook Share on Linkedin
stroke
Researchers tracked data from more than 1,000 patients who received care from 2014 to 2020. 
READ MORE >

Adding icosapent ethyl to statin therapy may reduce risk of stroke by 36%

Icosapent ethyl is an FDA-approved medication typically prescribed to limit triglycerides in the blood.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Adding icosapent ethyl to statin therapy may reduce risk of stroke by 36%

Share on Twitter Share on Facebook Share on Linkedin
Icosapent ethyl is an FDA-approved medication typically prescribed to limit triglycerides in the blood.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Week in Review: Former ACC president dies | Administration questions vascular care | Is coffee bad for the heart | FFR-CT guide
New-look pacemaker uses ultrasound to stimulate the heart | Heartflow reports significant revenue growth | CCTA & CTO PCI
New FFR-CT standardization consensus document | FDA clears first tricupid surgical valve | ECG AI to detect amyloidosis
Shockwave Medical's new IVL catheter | BATMAN to the rescue | Antiplatelet drugs after PCI | FDA announces recalls
When TAVR patients require surgery later in life | Colleagues pay tribute to a cardiology powerhouse | Much more
TAVR Highlights: Self-expanding valves continue to impress | A new technique | Why implant depth matters | SAPT vs. DAPT
Recall announced after 3 injuries | Medical societies respond to government report | New-look pacemaker requires no implant

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme